Edition:
India

Xenetic Biosciences Inc (XBIO.OQ)

XBIO.OQ on NASDAQ Stock Exchange Capital Market

4.17USD
1:30am IST
Change (% chg)

$-0.43 (-9.35%)
Prev Close
$4.60
Open
$4.61
Day's High
$4.63
Day's Low
$3.99
Volume
35,447
Avg. Vol
99,708
52-wk High
$8.94
52-wk Low
$1.45

Chart for

About

Xenetic Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on discovery, research and development of biologic drugs and novel oncology therapeutics. The Company’s lead investigational product candidate is oncology therapeutic XBIO-101, which is used for the treatment of progestin - resistant... (more)
No analyst recommendations are available for .

Overall

Beta: 1.04
Market Cap(Mil.): $40.10
Shares Outstanding(Mil.): 8.72
Dividend: --
Yield (%): --

Financials

Competitors

  Price Chg
Actelion Ltd (ATLN.S) -- --
Incyte Corporation (INCY.OQ) $70.11 -0.08

Earnings vs. Estimates